<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04593108</url>
  </required_header>
  <id_info>
    <org_study_id>Treatment of missedmiscarriage</org_study_id>
    <nct_id>NCT04593108</nct_id>
  </id_info>
  <brief_title>Misoprostol With or Without Letrozole in Treatment of Missed Miscarriage</brief_title>
  <official_title>Study at Zagazig General Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr.Dalia Mohammed Al Sayed Zaki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Benha University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Benha University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of study Compare the success rate of misoprostol with versus without letrozole as a&#xD;
      pretreatment for medical termination of pregnancy during the first trimester.&#xD;
&#xD;
      Hypothesis:&#xD;
&#xD;
      Letrozole value as a pre-treatment medication for misoprostol in induction of abortion during&#xD;
      the first trimester.&#xD;
&#xD;
      Research question:&#xD;
&#xD;
      Will letrozole- misoprostol protocol give better results than misoprostol- alone protocol in&#xD;
      induction of abortion during the first trimester?&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of the Work&#xD;
&#xD;
      Compare the success rate of misoprostol with versus without letrozole as a pretreatment for&#xD;
      medical termination of pregnancy during the first trimester.&#xD;
&#xD;
      Hypothesis:&#xD;
&#xD;
      Letrozole value as a pre-treatment medication for misoprostol in induction of abortion during&#xD;
      the first trimester.&#xD;
&#xD;
      Research question:&#xD;
&#xD;
      Will letrozole- misoprostol protocol give better results than misoprostol- alone protocol in&#xD;
      induction of abortion during the first trimester?&#xD;
&#xD;
      Primary outcome:&#xD;
&#xD;
      Complete abortion (complete expulsion of products of conception with no need for curettage)&#xD;
      within one week from the first dose of misoprostol.&#xD;
&#xD;
      Secondary outcome:&#xD;
&#xD;
      • Curettage (surgical evacuation of the products of conception)&#xD;
&#xD;
        -  Incomplete abortion (retained products of conception).&#xD;
&#xD;
        -  Considerable bleeding that necessitates immediate evacuation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 15, 2019</start_date>
  <completion_date type="Anticipated">November 15, 2020</completion_date>
  <primary_completion_date type="Actual">October 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Complete abortion</measure>
    <time_frame>1week</time_frame>
    <description>Complete abortion (complete expulsion of products of conception with no need for curettage) within one week from the first dose of misoprostol.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Missed Abortion</condition>
  <arm_group>
    <arm_group_label>Letrozole misoprostol</arm_group_label>
    <description>Group (A):&#xD;
A participant will receive three tablets of letrozole (Letrozole®, Technopharma) as a single dose, each tablet 2.5 mg (total dose 7.5 mg per day) on day One, then she took the second dose herself on day Two and will be told to bring back the empty pack. The third dose will be given on admission to hospital on day Three followed by 4 tablets of vaginal misoprostol (200 μg) (Cytotec®, Pfizer) soaked with saline every three hours for maximum two doses.then give antibiotics when abortion start</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Misoprostol,placebo</arm_group_label>
    <description>Group (B):&#xD;
A participant will receive three tablets of placebo as a single dose on day One, then she took the second dose herself on day Two and will be told to bring back the empty pack. The third dose will be given on admission to hospital on day Three followed by 4 tablets of vaginal misoprostol (200 μg) (Cytotec®, Pfizer) soaked with saline every three hours for maximum two doses.then give antibiotics when abortion start</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Letrozole misoprostol</intervention_name>
    <description>Letrozole give pretreatment of abortion by misoprostol</description>
    <arm_group_label>Letrozole misoprostol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol, placebo</intervention_name>
    <description>Give placebo pretreatment of abortion by misoprostol</description>
    <arm_group_label>Misoprostol,placebo</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study Settings:&#xD;
&#xD;
        This clinical trial will be conducted in department of obstetrics and gynecology at Zagazig&#xD;
        General Hospital during the period between January 2019 and June 2019.&#xD;
&#xD;
        Study Population:&#xD;
&#xD;
        The patients will be recruited from women attending outpatient clinic of obstetrics or the&#xD;
        emergency room of Zagazig General Hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Woman age more than 18 years old (age of legal consent).&#xD;
&#xD;
          -  BMI ranges between 25 kg/m2 and 35 kg/m2.&#xD;
&#xD;
          -  Gestational age of 63 days' gestation (or less).&#xD;
&#xD;
          -  Missed abortion.&#xD;
&#xD;
          -  Hemoglobin leve&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Woman age less than 18 years old.&#xD;
&#xD;
          -  BMI less than 25 kg/m2 or more than 35 kg/m2.&#xD;
&#xD;
          -  Gestational age more than 63 days' gestation.&#xD;
&#xD;
          -  Molar pregnancy.&#xD;
&#xD;
          -  Hemoglobin level less than 10 gm/dL.&#xD;
&#xD;
          -  Fibroid uterus.&#xD;
&#xD;
          -  Uterus with congenital anomalies.&#xD;
&#xD;
          -  Previous attempts for induction of abortion in the current pregnancy.&#xD;
&#xD;
          -  Coagulation defect i.e. coagulopathy.&#xD;
&#xD;
          -  Contraindication for induction of abortion e.g. heart failure.&#xD;
&#xD;
          -  Allergy to misoprostol or letrozole.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zagazig General hospital, Ministry hospital</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zagazig general hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dalia Mohammed Al Sayed Zaki</name>
      <address>
        <city>Zagazig</city>
        <state>Sharqia</state>
        <zip>1436</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/21252745/</url>
    <description>Misoprostol with or without letrozole pretreatment for termination of pregnancy: a randomized controlled trial</description>
  </link>
  <results_reference>
    <citation>Lee VCY, Ng EHY, Yeung WSB, Ho PC. Misoprostol with or without letrozole pretreatment for termination of pregnancy: a randomized controlled trial. Obstet Gynecol. 2011 Feb;117(2 Pt 1):317-323. doi: 10.1097/AOG.0b013e3182073fbf.</citation>
    <PMID>21252745</PMID>
  </results_reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 13, 2020</study_first_submitted>
  <study_first_submitted_qc>October 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>October 19, 2020</last_update_submitted>
  <last_update_submitted_qc>October 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Benha University</investigator_affiliation>
    <investigator_full_name>Dr.Dalia Mohammed Al Sayed Zaki</investigator_full_name>
    <investigator_title>Banha university</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abortion, Missed</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Letrozole</mesh_term>
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://www.ncbi.nlm.nih.gov/m/pubmed/?term=Misoprostol+with+or+without+letrozole+in+treatment+of+missed+miscarriage+in+first+trimester+%5BJour%5D+AND+2018%5Bpdat%5D</doc_url>
      <doc_comment>Albrecht ED, Aberdeen GW, Pepe GJ, (2000). The role of estrogen in the maintenance of primate pregnancy. Am J Obstet Gynecol. 182:432-8.&#xD;
Albrecht ED, Robb VA, Pepe GJ, (2004). Regulation of placental vascular endothelial growth permeability factor expression and angiogenesis by estrogen during early baboon pregnancy. J Clin Endocrinol Metab. 89:</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

